The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic characterization of thymic epithelial tumor from real-world data.
 
Kana Kurokawa
No Relationships to Disclose
 
Takehito Shukuya
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Kyowa Kirin; Lilly Japan; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca; Chugai Pharma; MSD
 
Ray Greenstein
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Benjamin G Kaplan
Employment - Foundation Medicine
Stock and Other Ownership Interests - Various investments; Various investments (I)
Consulting or Advisory Role - Biotech Venture Fund (I)
Research Funding - Foundation Medicine
Other Relationship - Biotech Venture Fund (I)
(OPTIONAL) Uncompensated Relationships - Biotech Venture Fund (I)
 
Heather A. Wakelee
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Mirati Therapeutics
Research Funding - ACEA Biosciences (Inst); Arrys Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Helsinn Therapeutics (Inst); Merck (Inst); Novartis (Inst); Seagen (Inst); Xcovery (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Merck
 
Keita Miura
No Relationships to Disclose
 
Kazuyuki Furuta
Employment - Chugai Pharma
 
Junghee Suh
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Ethan Sokol
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Submitted patent for HRD calling methodology (Inst)
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb Japan; Daiichi Sankyo; Eisai; EMD Serono; Flame Biosciences; Genentech/Roche; Geneplus; GlaxoSmithKline; Gritstone Bio; Intellisphere; Janssen; Johnson & Johnson/Janssen; Lilly; Merck; Mirati Therapeutics; Novocure; OncoCyte; Oncohost; Regeneron; Roche China; Sanofi; Seagen
Research Funding - Bristol-Myers Squibb
 
Kazuhisa Takahashi
Speakers' Bureau - AstraZeneca